Skip to main content
OpenTrials
Completed

NCT Number: NCT02681458

Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran

The purpose of this study was about survey of prevalence of fungal infections among drug users referring to methadone wards of Hospitals in northeast region of Iran

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Islamic Azad University of Mashhad

Mashhad, Razavi Khorasan Province, Iran

About this study

There were two groups with overall members of 1436. Statistically, the investigators have used "Likelihood ratio " and " Exact's Fisher" tests.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected fungal lesions

Exclusion criteria

  • non use of local or edible anti-fungal drugs and not taking bath within the last 48 hours of testing

Treatment and study plan

Direct Examination

Other

It was an observational study and subjects received their routine treatment.

Primary outcomes

  1. The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users

    Time frame: up to two months

Sponsors and collaborators

Lead sponsor

Islamic Azad University of Mashhad

Other

Registry information

Official study title

The Comparison of Dermatophytosis and Other Fungal Infections Between Drug Users and Non Drug Users

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Feb 12, 2016
Registry last updated
May 20, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.